Valued at USD 1.77 billion in 2025, the global catheter stabilization devices market is projected to reach USD 1.86 billion in 2026 and USD 2.74 billion by 2034, growing at a CAGR of 4.98% during the forecast period 2026–2034. Key players profiled by Polaris Market Research include 3M Company, Becton, Dickinson and Company, Baxter International Inc., Cardinal Health Inc., Convatec Group plc, ICU Medical Inc., Merit Medical Systems Inc., B. Braun SE, Medline Industries LP, Smiths Medical, Centurion Medical Products, and Dale Medical Products Inc. Rising hospital admissions, more surgeries, and a stronger infection prevention focus are the key drivers.

Infection Prevention Strengthens the Value Case

Hospitals are placing higher focus on reducing catheter-related bloodstream infections and urinary tract infections through standardized securement practices. Infection prevention recommendations from bodies such as the CDC and the Infusion Nurses Society are compelling healthcare providers to adopt advanced, secure devices.

Unplanned catheter movement often increases replacement procedures, nursing workload, and treatment delays. As providers adopt value-based care, procurement teams increasingly view stabilization devices as an investment in patient safety rather than a mere expense.

Stabilization devices for central venous catheters, PICC lines, peripheral IV catheters, and urinary catheters are becoming increasingly popular in healthcare settings. Product reliability, skin compatibility, infection prevention performance, regulatory compliance, and pricing remain key competitive factors in this moderately fragmented market.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/catheter-stabilization-devices-market

Hospital-Acquired Infections Raise the Stakes

According to the European Centre for Disease Prevention and Control, more than 3.5 million healthcare-associated infection cases occur annually across the EU/EEA, causing over 90,000 deaths. This burden supports demand for advanced catheter securement products in Europe. Growing awareness of hospital-acquired infections in China, India, Japan, and South Korea is also contributing to Asia Pacific's projected CAGR of 6.83%, the fastest of any region.

Rising procedure volumes add to demand. Eurostat reported 4.73 million cataract surgeries in the EU in 2022, the most frequently conducted surgery, alongside 1.10 million cesarean deliveries.

According to the U.S. Centers for Disease Control and Prevention, correct handwashing practices, use of PPE, sanitization, and safety precautions are key factors in preventing hospital-acquired infections, which is why medical practitioners have been integrating engineered stabilization devices to minimize catheter migration.

Home Healthcare Providers Drive the Fastest Growth

The home healthcare providers segment is projected to grow at the fastest end-user CAGR of 6.59% during the forecast period, owing to rising home infusion therapy, elderly care demand, and chronic disease management. Long-term catheter management is expanding across many countries, and patients and caregivers increasingly want easy-to-use, comfortable stabilizers.

The report identifies this as an emerging opportunity for manufacturers, although hospitals still held the largest end-user share of 68.00% in 2025. Easy-to-use stabilization devices are supporting adoption in home settings.

Advanced Securement Technologies Reshape Demand

Key product innovations include skin-friendly adhesives, antimicrobial securement pads, and catheters that do not require sutures. These products help minimize skin damage, increase patient comfort, and promote extended catheter dwell times. Premium products also reduce dressing changes and improve clinical efficiency.

The Catheter Stabilization Devices report notes that the advanced securement category is smaller than the traditional category but is growing faster. Innovations in adhesive technologies, antimicrobials, and release systems have positively affected product design.

Wider catheter-related activity includes Reflow Medical's April 2026 U.S. launch of next-generation Cora Flex and Cora Force torqueable microcatheters, engineered for improved navigation, torqueability, and lesion crossing during difficult coronary procedures.

Cost Barriers and Digital Procurement

High product cost compared with adhesive tape limits adoption in price-sensitive hospitals. Engineered stabilizers carry a higher unit price than conventional tape-based options, and budget-strapped public hospitals and small facilities still favor lower-cost alternatives.

Digital procurement is easing access for manufacturers. In September 2025, Oracle launched AI-based solutions for the healthcare supply chain to support efficient procurement operations at lower cost for hospitals, helping manufacturers improve product visibility and strengthen institutional sales channels. North America held the largest regional share, at 42.00% in 2025.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market